contador gratuito PATIENT73-


Ensayos clínicos


Por fecha inicio

Por fecha reclutamiento

Por fecha final



desde
hasta
desde
hasta
desde
hasta
 
       
Por enfermedad Por entidad Por estado Por país
       
Por promotor Buscar por nombre    
   
     


    Ensayo Promotor Enfermedad  



  Phase I Clinical Study of Dose-escalation Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of Recombinant Anti-FGFR Human-mouse Chimeric Monoclonal Antibody Injection BK011 in Patients with Advanced Malignant Solid Tumors

Inicio: 18/5/2022
Reclutamiento:
Final:

Estado: En proceso
Zhejiang Newind Biotechnology Co. Esophageal Neoplasms; Stomach Neoplasms



  Phase I/II Clinical Study of Mitoxantrone Hydrochloride Liposomes in Combination With Gemcitabine, Dexamethasone, and Cisplatin in Relapsed/Refractory Peripheral T-cell Lymphoma

Inicio: 1/5/2022
Reclutamiento:
Final:

Estado: En proceso
Peking Union Medical College Hospital, CAMS CSPC Pharmaceutical Group Co./CSPC Ouyi Pharmaceutical Co. Lymphoma; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral



  Single arm and single center clinical study on safety, tolerance and efficacy of GC101 injection in patients with type 1 spinal muscular atrophy

Inicio: 16/2/2022
Reclutamiento:
Final:

Estado: En proceso
(Other Hospital/Academic/Medical Center) GeneCradle Spinal Muscular Atrophy



  Clinical Study on the Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer

Inicio: 2/4/2021
Reclutamiento:
Final:

Estado: En proceso
Shanghai Biomed-Union Biotechnology Co. Pancreatic Neoplasms



  Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for Injection in the Treatment of Relapsed or Relapsed and Refractory Multiple Myeloma

Inicio: 26/6/2022
Reclutamiento:
Final:

Estado: En proceso
CASI Pharmaceuticals {EntreMed} (Other Hospital/Academic/Medical Center) Multiple Myeloma; Neoplasms, Plasma Cell



  A Phase I study of ZS801 injection, an rAAV gene therapy drug of Sichuan Zhishan Weixin Biotechnology Co., Ltd., in hemophilia B subjects.

Inicio: 1/1/1900
Reclutamiento:
Final:

Estado: En proceso
Sichuan Zhishan Weixin Biotechnology Co. Blood Coagulation Disorders; Hemophilia B; Hemostatic Disorders



  A Phase I Clinical Study of CD70-targeting CAR-T Therapy in the Treatment of Advanced/Metastatic Renal Cell Carcinoma

Inicio: 31/12/2021
Reclutamiento:
Final:

Estado: En proceso
Chongqing Precision Biotech Co. Carcinoma; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasm Metastasis; Wilms Tumor



  This is a Phase I Clinical Study to Evaluate the Safety and Efficacy of CAR-T Infusion Preparation in the Treatment of CD19-positive Relapsed/Refractory Non-Hodgkin Lymphoma

Inicio: 6/9/2021
Reclutamiento:
Final:

Estado: En proceso
Chongqing Precision Biotech Co. Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin



  An Open, Single-armed, Phase I Study to Evaluate the Safety and Efficacy Using Autologous TIL in Patients With Advanced Malignant Solid Tumors

Inicio: 14/6/2022
Reclutamiento:
Final:

Estado: En proceso
Shanghai Gencells Therapeutics Co. Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactions; Head and Neck Neoplasms; Melanoma; Neoplasms; Uterine Cervical Neoplasms



  A Phase I Clinical Study of Anti-CEA CAR-T Therapy in the Treatment of CEA-positive Advanced Malignant Solid Tumors

Inicio: 10/9/2021
Reclutamiento:
Final:

Estado: En proceso
Chongqing Precision Biotech Co. Colorectal Neoplasms; Esophageal Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Recurrence; Stomach Neoplasms